Common variants in the ATP‐sensitive K+channel genes KCNJ11(Kir6.2) and ABCC8(SUR1) in relation to glucose intolerance: population‐based studies and meta‐analyses1
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims To evaluate the relation between common variants in the ATP‐sensitive K+channel genes and glucose intolerance. Methods We conducted a meta‐analysis of reported association studies in Caucasian populations for common variants in the ABCC8(exons 16 and 18) and the KCNJ11(E23K) gene and examined sources of heterogeneity in the results. The meta‐analysis was based on 7768–10216 subjects (depending on the gene variant), and included two new population‐based studies in the Netherlands with 725 cases and 742 controls. Results For the KCNJ11 variant, the summary odds ratio (OR) for glucose intolerance was 1.12 (1.01–1.23,P = 0.03) for the EK genotype and 1.44 (1.17–1.78,P = 0.0007) for the KK genotype, as compared with the EE genotype. For the ABCC8 exon 16 variant, the OR was 1.06 (0.94–1.19,P = 0.34) for ct and 0.93 (0.71–1.20,P = 0.56) for tt, as compared with the cc genotype. For ABCC8 exon 18, the OR was 1.20 (0.97–1.49, P = 0.10) for CT/TT, as compared with the CC genotype. Studies of the ABCC8 variants that were published first or had smaller sample sizes (for the exon 18 variant) showed stronger associations, which may indicate publication bias. For the ABCC8 exon 18 and the KCNJ11 variant, associations were stronger for studies of clinical diabetes than newly detected glucose intolerance. The population attributable risk for clinical Type 2 diabetes was 6.2% for the KCNJ11 KK genotype and 10.1% for the KCNJ11 EK and KK genotype combined. Conclusions The common KCNJ11 E23K gene variant, but not the ABCC8 exon 16 or exon 18 variant, was consistently associated with Type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Diabetes mellitus and genetically programmed defects in β-cell function
Bell, G. I., & Polonsky, K. S. (2001) · Nature · doi:10.1038/414788a · Cited by 475
Sakura, H., Wat, N., Horton, V., Millns, H., Turner, R. C., & Ashcroft, F. M. (1996) · Diabetologia · doi:10.1007/bf02658512 · Cited by 122
Cited by
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 293
Scott, L. J., Bonnycastle, L. L., Willer, C. J., Sprau, A. G., Jackson, A. U., Narisu, N., Duren, W. L., Chines, P. S., Stringham, H. M., Erdos, M. R., et al. (2006) · Diabetes · doi:10.2337/db06-0341 · Cited by 236
Ostenson, C.-G., Gaisano, H., Sheu, L., Tibell, A., & Bartfai, T. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db04-1575 · Cited by 232
Ahlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Metadata
- Authors
- Van Dam, R. M., Hoebee, B., Seidell, J. C., Schaap, M. M., De Bruin, T. W. A., & Feskens, E. J. M.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2005-04-18
- Volume
- 22
- Issue
- 5
- Pages
- 590-598
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1990471536
- Cited by
- 89
- References
- 4
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.